Beobachtung von Langzeitnebenwirkungen bei Überlebenden kindlicher Krebserkrankungen

Armenian SH, Hudson MM, Mulder RL et al (2015) Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol 16:e123–e136 Bhakta N, Liu Q, Ness KK et al (2017) The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE). Lancet 390:2569–2582 Brignardello E, Felicetti F, Castiglione A et al (2013) Endocrine health conditions in adult survivors of childhood cancer: the need for specialized adult-focused follow-up clinics. Eur J Endocrinol 168:465–472 Byrne J, Alessi D, Allodji SR, Bagnasco F, Bárdi E, Bautz A, Bright CJ, Brown M, Diallo I, Feijen EAM, Fidler MM, Frey E, Garwicz S, Grabow D, Gudmundsdottir T, Hagberg O, Harila-Saari A, Hau EM, Haupt R, Hawkins MM, Jakab Z, Jankovic M, Kaatsch P, Kaiser M, Kremer LCM, Kuehni CE, Kuonen R, Ladenstein R, Lähteenmäki PM, Levitt G, Linge H, Lanas D, Michel G, Morsellino V, Mulder RL, Reulen RC, Ronckers CM, Sacerdote C, Skinner R, Steliarova-Foucher E, van der Pal HJ, de Vathaire F, Vũ Bezin G, Wesenberg F, Wiebe T, Winter DL, Winther JF, Witthoff E, Lona Zadravec Zaletel L, Hjorth L (2018a) The PanCareSurFupPanCareSurFup Consortium: research and guidelines to improve lives for survivors of childhood cancer. Eur J Cancer 103:238–248 Byrne J, Grabow D, Campbell H, O’Brien K, Bielack S, am Zehnhoff-Dinnesen A, Calaminus G, Kremer L, Langer T, van den Heuvel-Eibrink M, van Dulmen-den Broeder E, Baust K, Bautz A, Beck J, Berger C, Binder H, Borgmann-Staudt A, Broer L, Cario H, Casagranda L, Clemens E, Deuster D, de Vries A, Dirksen U, Falck Winther J, Font-Gonzalez A, Fossa S, Grandage V, Haupt R, Hecker-Nolting S, Hjorth L, Kaiser M, Kenborg L, Kepak T, Kepakova K, Knudsen L, Krawczuk-Rybak M, Kruseova J, Kuehni CE, Kunstreich M, Kuonen R, Lackner H, Leiper A, Loeffen E, Luks A, Modan-Moses D, Mulder R, Parfitt R, Paul N, Ranft A, Ruud E, Schilling R, Spix C, Stefanowicz J, Strauβ G, Uitterlinden A, van den Berg M, van der Kooi AL, van Dijk M, van Leeuwen F, Zolk O, Zoller D, Kaatsch P, PanCareLIFE Consortium (2018b) PanCareLIFE: The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity, and health related quality of life after cancer occurring among children and adolescents. Eur J Cancer 103:227–237 Calaminus G, Kaatsch P, Creutzig U, Langer T (2013) Erste Basiserhebung zu Lebenssituation, Gesundheitszustand und Lebensqualität bei Überlebenden nach Krebs im Kindesalter in Deutschland („VIVE“). Monatsschr Kinderheilkd 161:1071–1072 Gebauer J, Lehnert H, Schmid SM et al (2018a) Late effects following childhood cancer treatment: a special challenge for transition medicine. Internist (Berl) 59:1157–1162 Gebauer J, Rieken S, Schuster S et al (2018b) Multidisciplinary Late Effects Clinics for Childhood Cancer Survivors in Germany – a Two-Center Study. Oncol Res Treat 41:430–436 Clement SC, Kremer LCM, Verburg FA et al (2018) Balancing the benefits and harms of thyroid cancer surveillance in survivors of childhood, adolescent and young adult cancer: recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium. Cancer Treat Rev 63:28–39 DCOG/SKION Guidelines for follow-up in survivors of childhood cancer 5 years after diagnosis (2014) https://www.skion.nl/workspace/uploads/vertaling-richtlijn-LATER-versie-final-okt2014_2.pdf. Zugegriffen: 18. Jan. 2018 Essig S, Skinner R, von der Weid NX, Kuehni CE, Michel G (2012) Follow-up programs for childhood cancer survivors in Europe: a questionnaire survey. PLoS ONE 7:e53201 Frobisher C, Glaser A, Levitt GA et al (2017) Risk stratification of childhood cancer survivors necessary for evidence-based clinical long-term follow-up. Br J Cancer 117:1723–1731 Grabow D, Kaiser M, Hjorth L, Byrne J, Alessi D, Allodji RS, Bagnasco F, Bárdi E, Bautz A, Bright CJ, de Vathaire F, Feijen EAM, Garwicz S, Hagberg O, Haupt R, Hawkins MM, Jakab Z, Kremer LCM, Kuehni CE, Kuonen R, Lähteenmäki PM, Reulen RC, Ronckers CM, Sacerdote C, Vu-Bezin G, Wesenberg F, Wiebe T, Winter DL, Falck Winther J, Zadravec Zaletel L, Kaatsch P, PanCareSurFup Consortium (2018) The PanCareSurFup cohort of 83,333 five-year survivors of childhood cancer: a cohort from 12 European countries. Eur J Epidemiol 33:335–349 Hjorth L, Haupt R, Skinner R et al (2015) Survivorship after childhood cancer: PanCare: a European network to promote optimal long-term care. Eur J Cancer 51:1203–1211 Hudson MM, Ness KK, Gurney JG et al (2013) Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA 309:2371–2381 Friedman DL, Whitton J, Leisenring W et al (2010) Subsequent neoplasms in 5‑year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 102:1083–1095 Langer T, Grabow D, Steinmann D, Wormann B, Calaminus G (2017) Late effects and long-term followup after cancer in childhood. Oncol Res Treat 40:746–750 Signorelli C, Wakefield CE, Fardell JE et al (2017) The impact of long-term follow-up care for childhood cancer survivors: a systematic review. Crit Rev Oncol Hematol 114:131–138 Kaatsch et al (2017) Jahresbericht Deutsches Kinderkrebsregister 2017. http://www.kinderkrebsregister.de/dkkr/ueberuns/uebersicht.html. Zugegriffen: 17. Jan. 2018 Hudson MM et al (2018) Long-term follow-up quidelines for survivors of childhodd, adolescent and young adult cancers. Version 5.0 – October 2018. http://www.survivorshipguidelines.org/pdf/2018/COG_LTFU_Guidelines_v5.pdf. Zugegriffen: 18. Feb. 2019 Miller KA, Wojcik KY, Ramirez CN et al (2017) Supporting long-term follow-up of young adult survivors of childhood cancer: correlates of healthcare self-efficacy. Pediatr Blood Cancer 64:358–363 Mulder RL, Kremer LC, Hudson MM et al (2013) Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol 14:e621–e629 Oeffinger KC, Mertens AC, Sklar CA et al (2006) Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355:1572–1582 Robison LL, Mertens AC, Boice JD et al (2002) Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Med Pediatr Oncol 38:229–239 Scholz-Kreisel P, Kaatsch P, Spix C, Schmidberger H, Marron M, Grabow D, Becker C, Blettner M (2018) Second malignancies following childhood cancer treatment in Germany from 1980 to 2014 – a registry-based analysis. Dtsch Arztebl Int 115:385–392 Sieswerda E, Postma A, van Dalen EC et al (2012) The Dutch Childhood Oncology Group guideline for follow-up of asymptomatic cardiac dysfunction in childhood cancer survivors. Ann Oncol 23:2191–2198 Skinner R, Wallace WH, Levitt G (2007) Long-term follow-up of children treated for cancer: Why is it necessary, by whom, where and how? Arch Dis Child 92:257–260 Trachtenberg BH, Landy DC, Franco VI et al (2011) Anthracycline-associated cardiotoxicity in survivors of childhood cancer. Pediatr Cardiol 32:342–353 Wong FL, Bhatia S, Landier W et al (2014) Cost-effectiveness of the children’s oncology group long-term follow-up screening guidelines for childhood cancer survivors at risk for treatment-related heart failure. Ann Intern Med 160:672–683 Grabow D, Spix C, Blettner M, Kaatsch P (2011) Strategy for long-term surveillance at the German Childhood Cancer Registry – an update. Klin Padiatr 223:159–164